Skip to main content
$0.64 $0.03 (4.6%)

04:00 PM EDT on 03/31/23

IsoRay, Inc. (NYSEMKT:ISR)

CAPS Rating: No stars

The Company develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases.

Current Price $0.64 Mkt Cap $177.8M
Open $0.61 P/E Ratio 0.00
Prev. Close $0.64 Div. (Yield) $0.00 (0.0%)
Daily Range $0.60 - $0.64 Volume 415,388
52-Wk Range $0.19 - $0.67 Avg. Daily Vol. 719,610

Caps

How do you think NYSEMKT:ISR will perform against the market?

Add Stock to CAPS Watchlist

All Players

30 Outperform
12 Underperform
 

All-Star Players

3 Outperform
4 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:ISR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Alacrity (< 20)
Submitted September 02, 2015

ISR a small medical device company, is already FDA approved and holds the paten, on Cesium-131 brachytherapy. ISR potentially cures cancer with outstanding results. MD Anderson, named the best cancer hospital, in America is now using the cesium-131.… More

TSIF (99.98)
Submitted June 24, 2014

This is my fourth time on this one after the spikes, averaging 15 points on each of the other three calls. Maybe it will bite me eventually, but as I've noted before, these ONE case, recycled Cesium news releases aren't an indication of revenue. They… More

Recent Community Commentary

Read the most recent pitches from players about ISR.

Recs

1
Member Avatar Alacrity (< 20) Submitted: 9/2/2015 1:31:13 PM : Outperform Start Price: $1.46 NYSE MKT:ISR Score: -168.08

ISR a small medical device company, is already FDA approved and holds the paten, on Cesium-131 brachytherapy. ISR potentially cures cancer with outstanding results. MD Anderson, named the best cancer hospital, in America is now using the cesium-131. MD Anderson will have the results on, November 7, 2015 . ISR earnings are on Sept 14, 2015, last quarter ISR beat the consensus. In May, CEO Dwight Babcock, commented on the small cell lung cancer result, the stock soared. A very negative press release was released by, Adam Feuerstein resulting in several law suits, the stock then plummeted. Given the outstanding results, of cesium 131 and the ability to cure cancer is a very positive indication this will soon be a winner. Thomson Reuters, just gave the stock a four star out of ten and expected price target of 25.00. I am long in ISR, and I am waiting for some very positive results.

Recs

0
Member Avatar JacksonFool805 (< 20) Submitted: 5/13/2014 5:08:55 PM : Outperform Start Price: $2.35 NYSE MKT:ISR Score: -188.82

They have a propriety cancer fighting treatment already FDA approved with a track record of over 80% effectiveness in patients. Up over 400% ytd and will continue to grow baby grow....

Recs

0
Member Avatar jpat34721 (< 20) Submitted: 5/6/2014 2:32:35 PM : Outperform Start Price: $2.56 NYSE MKT:ISR Score: -194.21

proprietary standard of care cancer therapy with proven results and expanding application.

Leaderboard

Find the members with the highest scoring picks in ISR.

Score Leader

DrDoofenshmirtz

DrDoofenshmirtz (98.51) Score: +249.22

The Score Leader is the player with the highest score across all their picks in ISR.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
BTE78 < 20 5/12/2014 Underperform 1Y $2.57 -75.87% +115.47% +191.34 0 Comment
Slade366 79.31 5/23/2014 Underperform 5Y $2.26 -72.60% +114.41% +187.01 0 Comment
ahknaten 73.32 10/15/2014 Underperform 5Y $1.28 -51.63% +119.89% +171.52 0 Comment
PutinDragon 65.59 3/27/2015 Underperform NS $1.59 -61.06% +99.07% +160.13 0 Comment
IdahoInvestor 27.60 3/6/2013 Underperform 5Y $0.54 +14.67% +163.73% +149.06 0 Comment
TinyCapsWatch 99.87 6/6/2016 Underperform 5Y $0.80 -22.94% +93.43% +116.36 0 Comment
Doppelganger 37.52 7/13/2016 Underperform 5Y $0.83 -25.54% +89.84% +115.38 0 Comment
Zencyclone 30.24 10/19/2016 Underperform 5Y $0.69 -10.25% +90.72% +100.96 0 Comment
warrenout2 93.92 11/15/2016 Underperform 5Y $0.59 +4.93% +88.15% +83.22 0 Comment
DrDoofenshmirtz 98.51 1/6/2021 Underperform 5Y $1.84 -66.35% +10.14% +76.49 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ISR.